Office of Postdoctoral Education,
Dingledine received his PhD in pharmacology under Avram Goldstein at Stanford in 1975. He received
postdoctoral training from Leslie Iversen and John
Dr. Dingledine’s research over the past 20 years has focused on the modulation of glutamate receptor-mediated synaptic transmission. His work as a whole integrates information from a variety of experimental strategies to contribute to a better understanding of epilepsy, with broad implications for other brain disorders including stroke and schizophrenia. His publications between 1990 and 1999 rank within the top 1% for impact factor in both neuroscience and pharmacology fields.
He was Editor of Molecular Pharmacology, which has the highest citation index worldwide of primary pharmacology journals. He has consulted for several major pharmaceutical companies, is currently on the scientific advisory boards of The Epilepsy TDP and of EmTech-Bio, is a co-founder of NeurOp, a biotech start-up, and serves on the Program Advisory Committee of Morehouse College Neuroscience Institute.
He and his wife have been married for 37 years and have two grown sons.